Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

Summary

The purpose of this study was to explore the efficacy and safety of LTP001 in participants with pulmonary arterial hypertension (PAH) to determine if LTP001 had an adequate clinical profile to warrant further clinical development in this indication.

Timeline

Start

2022-06-30

Primary completion

2024-03-20

Completion

2024-04-25

Drugs

Indications